Skip to main content
OpenTrials

Clinical trial condition

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

Explore clinical trials studying Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women trial results

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

NCT02940522

Conditions
Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women
Locations
  • Anaheim, California, United States
  • DeLand, Florida, United States
  • Miami, Florida, United States
  • Orlando, Florida, United States
View Trial Details